ReviewRSC advances2026
Synthetic strategies in mono-styrylpyridines: building blocks for advanced applications.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents a comprehensive review of mono-styrylpyridines, a significant class of heterocyclic compounds renowned for their distinctive photophysical properties and diverse biological activities. The review systematically examines the principal synthetic strategies employed for their construction, with a particular focus on the versatility and efficiency of the Knoevenagel condensation, while also exploring alternative routes such as the Wittig and Heck reactions. Furthermore, it provides an overview of chemical transformations these compounds undergo, including photochemical dimerization processes, and their utility as ligands in coordination chemistry. This review aims to highlight the structural diversity and synthetic potential of mono-styrylpyridine compounds in the field of optoelectronics and pharmaceuticals, and to encourage further research in this interesting research area.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.